Aimed Alliance
Navigate
  • Home
  • About
    • Mission, Vision, Beliefs
    • Staff
    • Board of Directors
    • Aimed Alliance Supporters
    • Annual Reports
    • Privacy Policy
  • Policy Priorities
  • Initiatives
    • Alternative Funding Programs
    • Copay Accumulator 101
    • Judicial Advocacy
    • Know Your Rights
    • Step Therapy
      • New York Step Therapy Reform
      • Arizona Access First Alliance
    • Prescription Drug Affordability Boards
  • Resources
    • All
    • Stakeholders
    • Aimed in the News
    • Health News & Lawsuits
    • Newsletters & Media
  • Maps
    • Bad Drug Ads
      • Active Legislation
      • Enacted Laws
    • Copay Accumulators
      • Active Legislation
      • Enacted Laws
    • Nonmedical Switching
      • Active Legislation
      • Enacted Laws
    • Prior Authorization
      • Active Legislation
      • Enacted Laws
    • Step Therapy
      • Active Legislation
      • Enacted Laws
    • Biomarker Testing
      • Active Legislation
      • Enacted Laws
    • Oral Parity
      • Enacted Laws
  • Events
  • Contact

Aimed Alliance Comments on Massachusetts’ Medicaid Section 1115 Waiver Request

0
By Aimed Alliance on October 20, 2017 Aimed Activity, Health Insurance Reform, Health Insurance Reforms:  Policy Activity, Policymakers

Aimed Alliance Comments on Massachusetts’ Medicaid Section 1115 Waiver Request. Read here.

 

Last Updated on May 10, 2019 by Aimed Alliance

Health Reform Medicaid State
Share. Twitter Facebook Pinterest LinkedIn Tumblr Email

Related Posts

  • June 2, 2026

    Aimed Alliance Releases Consumer and Employer Guides on AFP Drug Importation Practices

  • June 1, 2026

    Aimed Alliance Resource Highlights PBM Delinking and Need for State Action

  • May 31, 2026

    Aimed Alliance Urges Opposition to Louisiana PDAB Bill, Citing Limited Patient Benefits

Comments are closed.

  • Aimed Alliance

  • Aimed Alliance is a 501 (c)(3) not-for-profit health policy organization that protects and enhances the rights of health care consumers and professionals.

    • Twitter
    • Facebook
    • Instagram
    • LinkedIn
    • YouTube